Viraj Mehta

Researcher        


Viraj mehta is a passionate innovator and researcher, specializing in complex in vitro models (CIVM) development. He obtained his PhD from Indian Institute of technology, Hyderabad (IIT-Hyderabad). He holds several patents, national awards and peer reviewed journal publications in the space of organ-on-chips and 3D culture models. He supports CROs and drug discovery companies in developing next generation microphysiological systems based biological & ADME assays. He is not only immersed in the technical side of things but also deeply involved in spreading knowledge and awareness about the potential of 3D culture models. He regularly creates content on LinkedIn that spans technical insights, well-being, and PhD-related guides and advice, aiming to inspire and educate a broader audience.

Contributing Author   in
Tools & Methods  

Disclaimer: All opinions, ideas, and thoughts expressed and posted by Contributors at BiopharmaTrend.com platform are their own personal points of view, and do not represent neither Contributor's employers, nor BiopharmaTrend.com.

Articles from Viraj

How Industry Embraces Organ-on-Chips: A 2024 Status Report

   3172
How Industry Embraces Organ-on-Chips: A 2024 Status Report

Report highlights:

  • We are currently at an exciting juncture where several big pharmaceutical companies have started adopting such models and conducted several exploratory studies

  • The last 4 years have witnessed at least twofold increase in industrial validation of organ-on-chips across various fields and organ models

  • The majority of the studies can be broadly categorized under ADME&T (ADME & toxicity) (55.7%) followed by disease modeling on chips (30%)

  • The rigorous industrial testing and strong backing from regulatory agencies indicate, the next 3-5 years can be a favorable investment opportunity in such models.

  • Industries and CROs seeking to invest in OoC field should prioritize establishing ADME related organ-models

  • Investors can prioritize their investment in the OoC companies that have major focus area in ADME&T sciences